These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17070046)

  • 1. Constrained azacyclic analogues of the immunomodulatory agent FTY720 as molecular probes for sphingosine 1-phosphate receptors.
    Hanessian S; Charron G; Billich A; Guerini D
    Bioorg Med Chem Lett; 2007 Jan; 17(2):491-4. PubMed ID: 17070046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists.
    Clemens JJ; Davis MD; Lynch KR; Macdonald TL
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3568-72. PubMed ID: 15982878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P.
    Kohno T; Igarashi Y
    Genes Cells; 2008 Jul; 13(7):747-57. PubMed ID: 18513330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
    Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP
    Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors.
    Osinde M; Mullershausen F; Dev KK
    Neuropharmacology; 2007 Apr; 52(5):1210-8. PubMed ID: 17379261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NBD-labeled derivatives of the immunomodulatory drug FTY720 as tools for metabolism and mode of action studies.
    Ettmayer P; Baumruker T; Guerini D; Mechtcheriakova D; Nussbaumer P; Streiff MB; Billich A
    Bioorg Med Chem Lett; 2006 Jan; 16(1):84-7. PubMed ID: 16236505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis.
    Dev KK; Mullershausen F; Mattes H; Kuhn RR; Bilbe G; Hoyer D; Mir A
    Pharmacol Ther; 2008 Jan; 117(1):77-93. PubMed ID: 17961662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric synthesis of conformationally constrained fingolimod analogues--discovery of an orally active sphingosine 1-phosphate receptor type-1 agonist and receptor type-3 antagonist.
    Zhu R; Snyder AH; Kharel Y; Schaffter L; Sun Q; Kennedy PC; Lynch KR; Macdonald TL
    J Med Chem; 2007 Dec; 50(25):6428-35. PubMed ID: 17994678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy.
    Sensken SC; Bode C; Gräler MH
    J Pharmacol Exp Ther; 2009 Mar; 328(3):963-9. PubMed ID: 19074680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720.
    Hale JJ; Neway W; Mills SG; Hajdu R; Ann Keohane C; Rosenbach M; Milligan J; Shei GJ; Chrebet G; Bergstrom J; Card D; Koo GC; Koprak SL; Jackson JJ; Rosen H; Mandala S
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3351-5. PubMed ID: 15149705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of sphingosine 1-phosphate receptor-3 (S1P(3)) agonism is essential, but inadequate to obtain immunomodulating 2-aminopropane-1,3-diol S1P(1) agonists with reduced effect on heart rate.
    Hamada M; Nakamura M; Kiuchi M; Marukawa K; Tomatsu A; Shimano K; Sato N; Sugahara K; Asayama M; Takagi K; Adachi K
    J Med Chem; 2010 Apr; 53(8):3154-68. PubMed ID: 20337461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
    Walter DH; Rochwalsky U; Reinhold J; Seeger F; Aicher A; Urbich C; Spyridopoulos I; Chun J; Brinkmann V; Keul P; Levkau B; Zeiher AM; Dimmeler S; Haendeler J
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):275-82. PubMed ID: 17158356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets.
    Huwiler A; Pfeilschifter J
    Biochem Pharmacol; 2008 May; 75(10):1893-900. PubMed ID: 18321471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S1P receptor mediated activity of FTY720 phosphate mimics.
    Högenauer K; Hinterding K; Nussbaumer P
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1485-7. PubMed ID: 20153186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.
    Matsuyuki H; Maeda Y; Yano K; Sugahara K; Chiba K; Kohno T; Igarashi Y
    Cell Mol Immunol; 2006 Dec; 3(6):429-37. PubMed ID: 17257496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression.
    Krump-Konvalinkova V; Chwalla I; Siess W
    Biochem Biophys Res Commun; 2008 Jun; 370(4):603-8. PubMed ID: 18402775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor.
    Vachal P; Toth LM; Hale JJ; Yan L; Mills SG; Chrebet GL; Koehane CA; Hajdu R; Milligan JA; Rosenbach MJ; Mandala S
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3684-7. PubMed ID: 16682185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.
    Schmid G; Guba M; Ischenko I; Papyan A; Joka M; Schrepfer S; Bruns CJ; Jauch KW; Heeschen C; Graeb C
    J Cell Biochem; 2007 May; 101(1):259-70. PubMed ID: 17203465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology.
    Brinkmann V
    Pharmacol Ther; 2007 Jul; 115(1):84-105. PubMed ID: 17561264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomer.
    Albert R; Hinterding K; Brinkmann V; Guerini D; Müller-Hartwieg C; Knecht H; Simeon C; Streiff M; Wagner T; Welzenbach K; Zécri F; Zollinger M; Cooke N; Francotte E
    J Med Chem; 2005 Aug; 48(16):5373-7. PubMed ID: 16078855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.